Introduction Lung cancer is one of the most common and deadliest malignant tumors worldwide, with an incidence and mortality rate of 11% and 20% in the United States in 2024, respectively, and this disease shows an increasing trend in incidence among females in China ( 1 , 2 ).
← all excerpts
Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer.
1
—
—